Literature DB >> 15548960

Donor brain death aggravates chronic rejection after lung transplantation in rats.

Noëlle Zweers1, Arjen H Petersen, Joost A B van der Hoeven, Aalzen de Haan, Rutger J Ploeg, Lou F M H de Leij, Jochum Prop.   

Abstract

BACKGROUND: Many recipients of lung transplants from brain-dead donors develop bronchiolitis obliterans, a manifestation of chronic rejection. It has been shown that brain death increases inflammatory mediators and accelerates acute rejection in kidney, liver, and heart transplants. In this study, the authors investigated the hypothesis that brain death increases inflammatory mediators in the donor lung and subsequently aggravates chronic rejection of the lungs after transplantation in rats.
METHODS: Brain death was induced in F344 rats by inflation of a subdurally placed balloon catheter. After 6 hr, donor lungs were assessed for influx of leukocytes, expression of cell adhesion molecules, and cytokine mRNA expression. For assessment of the lung after transplantation, lungs from brain-dead F344 rats were transplanted into WKY rats. Lung function after transplantation was monitored by chest radiographs during an observation period of 100 days. At the end of this period, the lungs were histologically examined; also, cytokine mRNA expression was measured. Lungs from ventilated living donors and living donors served as controls.
RESULTS: After 6 hr of brain death, influx of polymorphonuclear cells and macrophages and expression of vascular cell adhesion molecule-1 in the donor lungs was increased. After transplantation at postoperative day 100, the lung function was significantly decreased compared with allografts from living donors. In the lung allografts from brain-dead donors, histologic symptoms of chronic rejection were obvious, including severe intimal hyperplasia but without bronchiolitis obliterans. Interleukin-2 mRNA was significantly increased in allografts from brain-dead donors compared with living donors.
CONCLUSIONS: This study shows that brain death induces an inflammatory response in the donor lung and subsequently aggravates chronic rejection after transplantation. This may explain the clinical difference in long-term function between lungs from cadaveric donors and living donors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548960     DOI: 10.1097/01.tp.0000142679.45418.96

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.

Authors:  Xue Lin; Wenjun Li; Jiaming Lai; Mikio Okazaki; Seiichiro Sugimoto; Sumiharu Yamamoto; Xingan Wang; Andrew E Gelman; Daniel Kreisel; Alexander Sasha Krupnick
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

Review 2.  Special issues in the management and selection of the donor for lung transplantation.

Authors:  Priyumvada M Naik; Luis F Angel
Journal:  Semin Immunopathol       Date:  2011-04-15       Impact factor: 9.623

Review 3.  Mechanisms of chronic rejection in cardiothoracic transplantation.

Authors:  Matthew J Weiss; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci       Date:  2008-01-01

4.  Inhibition of Endoplasmic Reticulum Stress Alleviates Lung Injury Induced by Brain Death.

Authors:  Hongwei Tang; Jiakai Zhang; Shengli Cao; Bing Yan; Hongbo Fang; Huapeng Zhang; Wenzhi Guo; Shuijun Zhang
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

5.  A sphingosine 1-phosphate 1 receptor agonist modulates brain death-induced neurogenic pulmonary injury.

Authors:  Saad Sammani; Ki-Sung Park; Syed R Zaidi; Biji Mathew; Ting Wang; Yong Huang; Tong Zhou; Yves A Lussier; Aliya N Husain; Liliana Moreno-Vinasco; Wickii T Vigneswaran; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-26       Impact factor: 6.914

6.  Influence of donor brain death duration on outcomes following heart transplantation: A United Network for Organ Sharing Registry analysis.

Authors:  Oliver K Jawitz; Vignesh Raman; Yaron D Barac; Jatin Anand; Chetan B Patel; Robert J Mentz; Adam D DeVore; Carmelo Milano
Journal:  J Thorac Cardiovasc Surg       Date:  2019-04-30       Impact factor: 5.209

7.  Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.

Authors:  Qi Cheng; Kunal Patel; Biao Lei; Lindsay Rucker; D Patterson Allen; Peng Zhu; Chentha Vasu; Paulo N Martins; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal:  Am J Transplant       Date:  2018-04-10       Impact factor: 8.086

Review 8.  Inflammatory triggers of acute rejection of organ allografts.

Authors:  Daniel N Mori; Daniel Kreisel; James N Fullerton; Derek W Gilroy; Daniel R Goldstein
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

9.  Effect of the systemic administration of methylprednisolone on the lungs of brain-dead donor rats undergoing pulmonary transplantation.

Authors:  Luiz Felipe Lopes Araujo; Arthur Rodrigo Ronconi Holand; Artur de Oliveira Paludo; Éverton Franco Silva; Luiz Alberto Forgiarini; Luiz Felipe Forgiarini; Mariel Barbachan E Silva; Cristiano Feijó Andrade
Journal:  Clinics (Sao Paulo)       Date:  2014-02       Impact factor: 2.365

10.  Association of Increased Plasma Interleukin-6 and TNF-α Levels in Donors with the Complication Rates in Liver Transplant Recipients.

Authors:  N Azarpira; S Nikeghbalian; K Kazemi; B Geramizadeh; Z Malekpour; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.